Alain U. Vetterli
Vorstandsvorsitzender bei A&M Corp.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Garry Paul McCann | M | 63 |
Pulmo BioTech, Inc.
 Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 Jahre |
| Peter B. Hirshfield | M | 78 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 16 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Vardakis | M | 59 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 Jahre |
| Matthew C. Lords | M | 55 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 3 Jahre |
| Robert Lawrence Banner | M | 80 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 1 Jahre |
| Ian Ilsley | M | 75 |
Pulmo BioTech, Inc.
Pulmo BioTech, Inc. Medical SpecialtiesHealth Technology Pulmo BioTech, Inc. engages in the development and marketing of medical technology and research. It offers molecular imaging compounds designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and other conditions afflicting the Pulmonary Circulation. The company was founded on July 20, 2006 and is headquartered in New York, NY. | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 6 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Alain U. Vetterli
- Persönliches Netzwerk
